The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study
Open accessAbstract
BACKGROUND: ). METHODS: and complete ethnicity data, were registered with a general practitioner practice in England at any point between Sept 1, 1990, and Dec 1, 2018, and had at least 1 year of follow-up data. Patients with type 2 diabetes were identified by use of a CALIBER phenotyping algorithm. Self-reported ethnicity was collapsed into five main categories. Age-adjusted and sex-adjusted negative binomial regression models, with fractional polynomials for BMI, were fitted with incident type 2 diabetes and ethnicity data. FINDINGS: (26·5-27·0) in Arab populations. INTERPRETATION: Revisions of ethnicity-specific BMI cutoffs are needed to ensure that minority ethnic populations are provided with appropriate clinical surveillance to optimise the prevention, early diagnosis, and timely management of type 2 diabetes. FUNDING: National Institute for Health Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The BMI cutoff of age- and sex-adjusted incidence for type 2 diabetes that is equivalent to the cutoff of 25 kg/m2 in the White population is as low as 19.2 kg/m2 in South Asians [39].”
From Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity (2024) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Physical Status: The Use and Interpretation of Anthropometry
Frisancho, A. R. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.5.830 · Cited by 6,569
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Self-citation
Cited by
Sorted by citations
Items 401–429 of 429
Considérer l’obésité comme une maladie
Laville, M. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.05.008
Volpini, L., & Carwile, L. P. (2026) · Journal of artificial intelligence for sustainable development. · doi:10.69828/4d4kxn
Roberts, C., Hodges, P., Badrulhisham, F., Smith, R., Pamment, D., Odeh, S., Kuk, N., Chauhan, A., Bewshea, C., Cairnes, V., et al. (2026) · Frontline Gastroenterology · doi:10.1136/flgastro-2026-103717
Wu, H., Wu, B., Chen, J. Q., Liu, S., 丁敏勇, 官缦丽, & Liu, J. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1851710
The evolving concepts in visceral obesity: What anesthesiologists need to know
Magoon, R., Choudhary, N., & Jose, J. (2026) · Saudi Journal of Anaesthesia · doi:10.4103/sja.sja_828_25
Guan, Z., Stephan, B. C. M., & Siervo, M. (2026) · Diabetes Care · doi:10.2337/dc26-0797
Racial/ethnic inequities in diabetes mellitus: a narrative review
Mazhude, T., Fanas, R. L., & Myers, A. K. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag277
Anthropometric and Metabolic Traits Across Ancestries in the UK Biobank
Roshandel, D., Paterson, A. D., & Dash, S. (2026) · Journal of Obesity · doi:10.1155/jobe/5149353
HbA1c Management of Endocrine Disorders and the Pharmacist's Role: Diabetes
Krass, I., Hoti, K., Khalil, H., Ludington, J. E., & Namara, K. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00021-8
van Laar, A. V., Pazmino, S., Mamouris, P., Steenackers, N., Vangoitsenhoven, R., Mertens, A., Deleus, E., Lannoo, M., Hulsmans, M., Simoens, C., et al. (2026) · Clinical Obesity · doi:10.1111/cob.70098
Unpacking adiposity: a narrative critical appraisal of diverse obesity definitions
Mancini, M. C., Halpern, B., de Melo, M. E., & Kramer, C. K. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02261-6
Persona-Guided LLM Adaptation for Culturally Personalized Diabetes Prevention MCQs
Fan, J., Fensore, C. M., Shtulman, J., Pai, R., Shoaib, D. M., Shah, M. K., & Ho, J. C. (2026) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi69079.2026.00125
Khalaf, R., Chow, W., Lazarowitz, R., Netchiporouk, E., Rao, J., Tardio, V., & Litvinov, I. V. (2026) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754261467034
Booker, C. L., Liang, Y., Meadows, A., Cranshaw, O., Dearman, A., Dilkes, E., Hignell, B., Malih, A., Navyte, G., & Meena Kumari, B. (2026) · SSM - Population Health · doi:10.1016/j.ssmph.2026.101962
Clinical Characteristics of Patients With Symptomatic Sigmoid Sinus Wall Anomalies
Wen, C. Z., Gomez, C. N., Fu, Y., Song, J., Nam, D. W., Hsieh, Y., Wang, W., & Eisenman, D. J. (2026) · OTO Open · doi:10.1002/oto2.70293
Teng, F., Li, S., & Liu, D. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1867835
Sah, U. K., Sudhanshu, S., Moirangthem, A., Dabadghao, P., & Bhatia, V. (2026) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_872_25
Choudhary, A., Altınkaynak, Y., & Altinkaynak, B. A. (2026) · Research Square · doi:10.21203/rs.3.rs-10950437/v1
Fabunmi, O. A., Mxinwa, V., Butt, K., Fabunmi, F. C., & Ajbare, A. J. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016927
Aniokete, U. C., Obasi, D. C., Uzor, S., Akwari, A. A., Okoroh, P. N., Emeruwa, A. P., Amadi, E. B., Eji, M. O., & Alum, E. U. (2026) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2026.200386
Childhood Maltreatment and Adult Obesity: Gender-Specific Pathways
Blumhagen, H. M., Helton, J. J., & Schultz, Z. S. (2026) · Child Maltreatment · doi:10.1177/10775595261490824
Tan, M. M., Ajibewa, T. A., Cursio, J., Hedeker, D., Sierra, A. M. G., Konuthula, D., & Jao, N. C. (2026) · Annals of Behavioral Medicine · doi:10.1093/abm/kaag057
Global barriers to GLP-1 receptor agonist treatment in women: access, safety, and equity
Meek, C. L., Anjana, R. M., Chandiwana, N. C., Chow, E. W. K., Franco, D. R., Halpern, B., Lamptey, R., Lingvay, I., Ma, R. C. W., Mohan, V., et al. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(26)00228-1
Dasgupta, K., Boulé, N. G., Henson, J. J., Redman, E. L., Chan, D., McCarthy, M., Rosa, D., Arsenyadis, F., Chevalier, S., Rees, J., et al. (2026) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2026.101664
Impact of Obesity and Its Treatment on Inflammatory Bowel Disease Outcomes: A Narrative Review
Redavid, C., Pirro, P., Bertin, L., & Savarino, E. V. (2026) · Gastroenterology Insights · doi:10.3390/gastroent17040057
Zaka, A., Khan, S., Shah, M., Khalid, A. A., Khalil, I., & Kamrul-Hasan, A. B. M. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70359
Kong, Y., Wang, W., 孙徐仁, Zhang, C., Wang, Z., Wang, H., Yue, X., & 赖亚新 (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101800
Roberts, C., Smith, R., Odeh, S., Kuk, N., Chauhan, A., Bewshea, C., Cairnes, V., Toll, H., Kennedy, N. A., Goodhand, J., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.71073
Metadata
- Authors
- Caleyachetty, R., Barber, T. M., Mohammed, N. I., Cappuccio, F. P., Hardy, R., Mathur, R., Banerjee, A., & Gill, P.
- Affiliations
- University Hospital Coventry (GB)
- Corresponding author
- Caleyachetty, Rishi
- ORCID
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 9
- Issue
- 7
- Pages
- 419-426
- ISSN
- 2213-8587 (ISSN-L)
- PMC
- PMC8208895
- OpenAlex
- W3162704165
- Cited by
- 429
- References
- 30
- Citations by year
- 2026: 87 · 2025: 100 · 2024: 82 · 2023: 81 · 2022: 61 · 2021: 18
- FWCI
- 45.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2021-07-01)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- South Asian Health Foundation
- National Institute for Health Research (PB-PG-1217\u201320038, 20038, PB-PG-1217)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, obesity, body mass index, ethnic minorities, Arabs, diabetes risk, diabetes prevention, clinical surveillance
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, England, Ethnicity, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Population Surveillance, Risk Factors, Cohort Studies, Body Mass Index, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
